Corrigendum to "Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis" [Int. Immunopharmacol. 131 (2024) 111826].

Authors :: Canto-Gomes J
Boleixa D
Teixeira C
da Silva AM
González-Suárez I
Cerqueira J
Correia-Neves M
Nobrega C
Source :: International immunopharmacology [Int Immunopharmacol] 2024 Dec 25; Vol. 143 (Pt 2), pp. 113555. Date of Electronic Publication: 2024 Nov 04.
Publication Year :: 2024

Full Text Access

Tools